29 August 2025 - Subcutaneous delivery increases accessibility and introduces potential for at home administration, following model of diabetes and ...
21 July 2022 - Submission supported by comprehensive analytical data package and clinical Phase I pharmacokinetics bridging study. ...
21 July 2022 - The ATAGI met on 20 July 2022 to consider the latest developments relating to COVID-19 immunisation. ...
21 July 2022 - Enfortumab vedotin is an antibody-drug conjugate targeting nectin-4, an adhesion protein located on the surface of epithelial ...
20 July 2022 - Using real world data –based trial simulation approach, we aim to simulate colorectal cancer trials and ...
15 July 2022 - Although there has been a significant increase in the number of U.S. residents insured through Medicaid since ...
20 July 2022 - With NHS England highlighting savings of £1.2 billion on medicines in three years coming from both ...
20 July 2022 - Oncopeptides today announces that the US FDA, has announced a forthcoming public advisory meeting of the ...
20 July 2022 - Vivus today announced that the U.S. FDA approved Qsymia (phentermine and topiramate extended-release capsules) for use in ...
20 July 2022 - FDA fast track designation and European Commission orphan medicinal product designation underscore the significant need for ...
20 July 2022 - From September women in the UK will be able to access Gina 10 microgram vaginal tablets without ...
19 July 2022 - Today is another step forward in our nation’s fight against the virus. Following an independent scientific review ...
19 July 2022 - Pfizer and BioNTech today announced they have completed a submission to the EMA for an Omicron-adapted bivalent ...
19 July 2022 - Wugen, today announced that the U.S. FDA has granted fast track designation and rare paediatric disease ...
19 July 2022 - Ascentage Pharma and Innovent Biologics today announce that the Center for Drug Evaluation of China's NMPA ...
19 July 2022 - Independent appraisal committee unanimously determined that evidence is adequate to demonstrate that beti-cel provides a net ...